Dermatological compositions and salts for the treatment of dermatological diseases

Details for Australian Patent Application No. 2006228871 (hide)

Owner Astion Pharma A/S

Inventors Weider, Morten Sloth

Agent FB Rice

Pub. Number AU-A-2006228871

PCT Pub. Number WO2006/102900

Priority PA 2005 00949 27.06.05 DK; 60/694,774 27.06.05 US; PA 2005 00437 30.03.05 DK; PA 2005 00948 27.06.05 DK; 60/695,040 28.06.05 US; PA 2005 00438 30.03.05 DK

Filing date 30 March 2006

Wipo publication date 5 October 2006

International Classifications

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/08 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102900 Priority application(s): WO2006/102900

28 February 2008 Amendment Made

  The nature of the amendment is: Amend inventor name from Weider, Morten Sloth to Weidner, Morten Sloth

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228872-Immunogenic EGFR peptides comprising foreign Tcell stimulating epitope

2006228870-Oxaprozin or closely related compound for the treatment and prevention of